Literature DB >> 20523272

Improving mortality in sepsis: analysis of clinical trials.

Flavia R Machado1, Bruno F Mazza.   

Abstract

Sepsis accounts for a huge number of deaths in intensive care units worldwide. Encouraging data from recent studies show that some interventions are able to reverse such a picture. Surviving Sepsis Campaign (SSC) bundles were built based on these interventions. Many studies were published analyzing the impact of sepsis protocol implementation on compliance, costs, and mortality, and the results are herein analyzed. Based on these studies, it is not clear if the reduction is secondary to improvement in the quality of care naturally associated with protocol implementation or to the improvement in compliance to strict goals. A high heterogeneity is present among institutions and countries, and the pitfalls for protocol implementation seem to depend on local characteristics. In the same way, the impact of interventions might be different according to each institution's epidemiological profile. Interventions not impacting in low-mortality-rate institutions can be important for places where mortality is high. In Brazil, mortality rates are very high, and the results of Brazilian SSC network are presented and discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523272     DOI: 10.1097/SHK.0b013e3181e7e8b4

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

1.  Impact of melatonin receptor deletion on intracellular signaling in spleen cells of mice after polymicrobial sepsis.

Authors:  Astrid Kleber; Sarah Altmeyer; Beate Wolf; Alexander Wolf; Thomas Volk; Tobias Fink; Darius Kubulus
Journal:  Inflamm Res       Date:  2014-10-29       Impact factor: 4.575

2.  Trichostatin A improves the inflammatory response and liver injury in septic mice through the FoxO3a/autophagy signaling pathway.

Authors:  Mei-Jia Shen; Li-Chao Sun; Xiao-Yu Liu; Meng-Chen Xiong; Shan Li; A-Ling Tang; Guo-Qiang Zhang
Journal:  World J Emerg Med       Date:  2022

3.  Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis.

Authors:  Sandra Dial; Sharon J Nessim; Abbas Kezouh; Jacques Benisty; Samy Suissa
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

4.  The impact of acute organ dysfunction on patients' mortality with severe sepsis.

Authors:  Takeshi Umegaki; Hiroshi Ikai; Yuichi Imanaka
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04

5.  Compliance with severe sepsis bundles and its effect on patient outcomes of severe community-acquired pneumonia in a limited resources country.

Authors:  Qi Guo; Hai-Yan Li; Yi-Min Li; Ling-Bo Nong; Yuan-Da Xu; Guo-Qing He; Xiao-Qing Liu; Mei Jiang; Zheng-Iun Xiao; Nan-Shan Zhong
Journal:  Arch Med Sci       Date:  2014-10-23       Impact factor: 3.318

6.  A prospective multicenter evaluation of direct molecular detection of blood stream infection from a clinical perspective.

Authors:  A E Nieman; P H M Savelkoul; A Beishuizen; B Henrich; B Lamik; C R MacKenzie; D Kindgen-Milles; A Helmers; C Diaz; S G Sakka; R P Schade
Journal:  BMC Infect Dis       Date:  2016-06-30       Impact factor: 3.090

7.  Peptidylarginine deiminase 4 concentration, but not PADI4 polymorphisms, is associated with ICU mortality in septic shock patients.

Authors:  Nara Aline Costa; Ana Lúcia Gut; Paula Schmidt Azevedo; Bertha Furlan Polegato; Eloá Siqueira Magalhães; Larissa Lumi Watanabe Ishikawa; Rita de Cassia Siqueira Bruder; Evelyn Aparecida da Silva; Renan Braga Gonçalves; Suzana Erico Tanni; Marcelo Macedo Rogero; Marina Maintinguer Norde; Natália Baraldi Cunha; Leonardo Antonio Mamede Zornoff; Sergio Alberto Rupp de Paiva; Marcos Ferreira Minicucci
Journal:  J Cell Mol Med       Date:  2018-07-25       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.